![Aaron Tward](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aaron Tward
Hoofd Techniek/Wetenschap/O&O bij
AKOUOS
Profiel
Aaron Tward is the founder of Affinia Therapeutics, Inc., founded in 2019.
Dr. Tward currently holds the positions of Associate Professor at The University of California, San Francisco since 2022 and Chief Scientific Officer at Akouos, Inc. since 2022.
Dr. Tward earned a doctorate degree from The University of California, San Francisco.
Actieve functies van Aaron Tward
| Bedrijven | Functie | Begin |
|---|---|---|
| AKOUOS | Hoofd Techniek/Wetenschap/O&O | 10-03-2022 |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-03-2022 |
Eerdere bekende functies van Aaron Tward
| Bedrijven | Functie | Einde |
|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Oprichter | - |
Opleiding van Aaron Tward
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
